Fingolimod exerts in vitro anticancer activity against hepatocellular carcinoma cell lines via YAP/TAZ suppression
Hepatocellular carcinoma (HCC) remains a notably global health challenge with high mortality rates and poor prognosis. The deregulation of the Hippo signalling pathway, especially the overexpression and activation of downstream effector Yes-associated protein (YAP), has been demonstrated to result i...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Sciendo
2022-09-01
|
| Serier: | Acta Pharmaceutica |
| Fag: | |
| Online adgang: | https://doi.org/10.2478/acph-2022-0029 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
